Jpmorgan Chase & Co »

Acumen Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $291k 72k 4.05
2023-12-31 $130k 34k 3.84
2023-09-30 $46k 11k 4.17
2023-06-30 $6.1k 1.3k 4.81
2023-03-31 $5.0k 1.2k 4.04
2022-12-31 $6.0k 1.1k 5.31
2022-06-30 $8.0k 1.6k 4.93
2022-03-31 $72k 18k 3.97
2021-12-31 $49k 7.2k 6.73